These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 1317371

  • 1. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
    Aubert G, Pozzetto B, Dorche G.
    J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371
    [Abstract] [Full Text] [Related]

  • 2. [The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem].
    Pascual A A, Joyanes P, Martínez-Martínez L, del Carmen Conejo M, Hernández G, Chaves J, Perea EJ.
    Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):432-4. PubMed ID: 11709121
    [Abstract] [Full Text] [Related]

  • 3. Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin.
    Rådberg G, Nilsson LE, Svensson S.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2142-7. PubMed ID: 2127345
    [Abstract] [Full Text] [Related]

  • 4. Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.
    Fass RJ, Barnishan J, Ayers LW.
    J Antimicrob Chemother; 1995 Aug; 36(2):343-53. PubMed ID: 8522464
    [Abstract] [Full Text] [Related]

  • 5. Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem.
    Cambau E, Perani E, Dib C, Petinon C, Trias J, Jarlier V.
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2248-52. PubMed ID: 8619577
    [Abstract] [Full Text] [Related]

  • 6. Resistance to fluoroquinolones in Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Rydberg J, Larsson C, Miörner H.
    Scand J Infect Dis; 1994 Oct; 26(3):317-20. PubMed ID: 7939432
    [Abstract] [Full Text] [Related]

  • 7. Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.
    Michéa-Hamzehpour M, Auckenthaler R, Regamey P, Pechère JC.
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1803-8. PubMed ID: 3124739
    [Abstract] [Full Text] [Related]

  • 8. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Fukuda H, Maeda S, Saito I, Kawada Y.
    Chemotherapy; 1997 Nov; 43(4):239-44. PubMed ID: 9209780
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
    Jalal S, Wretlind B.
    Microb Drug Resist; 1998 Nov; 4(4):257-61. PubMed ID: 9988043
    [Abstract] [Full Text] [Related]

  • 10. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
    Kotera Y, Inoue Y, Ohashi M, Ito K, Tsukamoto G.
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
    [Abstract] [Full Text] [Related]

  • 11. In-vitro susceptibilities of Pseudomonas aeruginosa and Pseudomonas spp. to the new fluoroquinolones clinafloxacin and PD 131628 and nine other antimicrobial agents.
    Ford AS, Baltch AL, Smith RP, Ritz W.
    J Antimicrob Chemother; 1993 Apr; 31(4):523-32. PubMed ID: 8390434
    [Abstract] [Full Text] [Related]

  • 12. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
    Lister PD, Wolter DJ.
    Clin Infect Dis; 2005 Feb 15; 40 Suppl 2():S105-14. PubMed ID: 15712098
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN, Kohlhepp SJ, Slama KA, Grunkemeier G, Lewis G, Dworkin RJ, Slaughter SE, Leggett JE.
    Antimicrob Agents Chemother; 2001 Mar 15; 45(3):883-92. PubMed ID: 11181375
    [Abstract] [Full Text] [Related]

  • 14. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.
    Chamberland S, Bayer AS, Schollaardt T, Wong SA, Bryan LE.
    Antimicrob Agents Chemother; 1989 May 15; 33(5):624-34. PubMed ID: 2502066
    [Abstract] [Full Text] [Related]

  • 15. Outer membrane alterations in Pseudomonas aeruginosa after five-day exposure to quinolones and carbapenems.
    Cipriani P, Giordano A, Magni A, Papa F, Filadoro F.
    Drugs Exp Clin Res; 1995 May 15; 21(4):139-44. PubMed ID: 8529526
    [Abstract] [Full Text] [Related]

  • 16. Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa.
    Michéa-Hamzehpour M, Furet YX, Pechère JC.
    Antimicrob Agents Chemother; 1991 Oct 15; 35(10):2091-7. PubMed ID: 1662023
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the bactericidal activity of trovafloxacin and ciprofloxacin, alone and in combination with cefepime, against Pseudomonas aeruginosa.
    McNabb J, Quintiliani R, Nightingale CH, Nicolau DP.
    Chemotherapy; 2000 Oct 15; 46(6):383-9. PubMed ID: 11053903
    [Abstract] [Full Text] [Related]

  • 18. [In vitro effect of new fluoroquinolones and betalactamines combinations against enterococci].
    Aubert G, Pozzetto B, Dorche G.
    Pathol Biol (Paris); 1991 Dec 15; 39(10):1006-8. PubMed ID: 1666668
    [Abstract] [Full Text] [Related]

  • 19. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC, Wang HB, Sun ZY, Shen ZY.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):403-7. PubMed ID: 12820918
    [Abstract] [Full Text] [Related]

  • 20. In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin.
    McGrath BJ, Marchbanks CR, Gilbert D, Dudley MN.
    Antimicrob Agents Chemother; 1993 Aug 10; 37(8):1723-5. PubMed ID: 8215293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.